Sambol NC - Search Results

1

Population Pharmacokinetic Properties of Piperaquine in Falciparum Malaria: An Individual Participant Data Meta-Analysis.

Hoglund RM, Workman L, Edstein MD, Thanh NX, Quang NN, Zongo I, Ouedraogo JB, Borrmann S, Mwai L, Nsanzabana C, Price RN, Dahal P, Sambol NC, Parikh S, Nosten F, Ashley EA, Phyo AP, Lwin KM, McGready R, Day NP, Guerin PJ, White NJ, Barnes KI, Tarning J. Hoglund RM, et al. Among authors: sambol nc. PLoS Med. 2017 Jan 10;14(1):e1002212. doi: 10.1371/journal.pmed.1002212. eCollection 2017 Jan. PLoS Med. 2017. PMID: 28072872 Free PMC article.

2

Rethinking Dosing Regimen Selection of Piperaquine for Malaria Chemoprevention: A Simulation Study.

Sambol NC, Tappero JW, Arinaitwe E, Parikh S. Sambol NC, et al. PLoS One. 2016 May 16;11(5):e0154623. doi: 10.1371/journal.pone.0154623. eCollection 2016. PLoS One. 2016. PMID: 27182702 Free PMC article.

3

Population Pharmacokinetics of Piperaquine in Young Ugandan Children Treated With Dihydroartemisinin-Piperaquine for Uncomplicated Malaria.

Sambol NC, Yan L, Creek DJ, McCormack SA, Arinaitwe E, Bigira V, Wanzira H, Kakuru A, Tappero JW, Lindegardh N, Tarning J, Nosten F, Aweeka FT, Parikh S. Sambol NC, et al. Clin Pharmacol Ther. 2015 Jul;98(1):87-95. doi: 10.1002/cpt.104. Epub 2015 May 2. Clin Pharmacol Ther. 2015. PMID: 25732044 Free PMC article.

4

Population Pharmacokinetics and Pharmacodynamics of Lumefantrine in Young Ugandan Children Treated With Artemether-Lumefantrine for Uncomplicated Malaria.

Tchaparian E, Sambol NC, Arinaitwe E, McCormack SA, Bigira V, Wanzira H, Muhindo M, Creek DJ, Sukumar N, Blessborn D, Tappero JW, Kakuru A, Bergqvist Y, Aweeka FT, Parikh S. Tchaparian E, et al. Among authors: sambol nc. J Infect Dis. 2016 Oct 15;214(8):1243-51. doi: 10.1093/infdis/jiw338. Epub 2016 Jul 28. J Infect Dis. 2016. PMID: 27471317 Free PMC article. Clinical Trial.

5

Interaction between structural, statistical, and covariate models in population pharmacokinetic analysis.

Wade JR, Beal SL, Sambol NC. Wade JR, et al. Among authors: sambol nc. J Pharmacokinet Biopharm. 1994 Apr;22(2):165-77. doi: 10.1007/BF02353542. J Pharmacokinet Biopharm. 1994. PMID: 7815312

6

Felodipine population dose-response and concentration-response relationships in patients with essential hypertension.

Wade JR, Sambol NC. Wade JR, et al. Among authors: sambol nc. Clin Pharmacol Ther. 1995 May;57(5):569-81. doi: 10.1016/0009-9236(95)90042-X. Clin Pharmacol Ther. 1995. PMID: 7768080 Clinical Trial.

7

Kidney function and age are both predictors of pharmacokinetics of metformin.

Sambol NC, Chiang J, Lin ET, Goodman AM, Liu CY, Benet LZ, Cogan MG. Sambol NC, et al. J Clin Pharmacol. 1995 Nov;35(11):1094-102. doi: 10.1002/j.1552-4604.1995.tb04033.x. J Clin Pharmacol. 1995. PMID: 8626883

8

Pharmacokinetics and pharmacodynamics of metformin in healthy subjects and patients with noninsulin-dependent diabetes mellitus.

Sambol NC, Chiang J, O'Conner M, Liu CY, Lin ET, Goodman AM, Benet LZ, Karam JH. Sambol NC, et al. J Clin Pharmacol. 1996 Nov;36(11):1012-21. doi: 10.1177/009127009603601105. J Clin Pharmacol. 1996. PMID: 8973990 Clinical Trial.

9

Study designs for dose-ranging.

Sheiner LB, Beal SL, Sambol NC. Sheiner LB, et al. Among authors: sambol nc. Clin Pharmacol Ther. 1989 Jul;46(1):63-77. doi: 10.1038/clpt.1989.108. Clin Pharmacol Ther. 1989. PMID: 2743708

10

Pharmacodynamic analysis of analgesic clinical trials: nonlinear mixed-effects logistic models.

Liu CY, Sambol NC. Liu CY, et al. Among authors: sambol nc. J Biopharm Stat. 1999 May;9(2):253-70. doi: 10.1081/BIP-100101175. J Biopharm Stat. 1999. PMID: 10379692

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters